Changsha Duxact Biotechnology

Changsha Duxact Biotechnology is an active Chinese contract research organization (CRO) founded in 2016. It provides comprehensive one-stop services for global clinical research on drugs and medical devices. Its offerings include subject recruitment, SMO services, sample analysis/testing (including bioequivalence studies), data management/statistical analysis compliant with international standards (CDISC), medical affairs support, pharmacovigilance/monitoring of drugs in the body, biomarker testing/precision medicine lab work, TCM genome quality analysis/barcoding/testing for heavy metals/pesticides. The company has over 700 employees and operates out of an 8,000 m² facility in Changsha High-Tech Industrial Development Zone[1][2][3]. It has established several subsidiaries focused on different aspects of the clinical trial process.